News

Find News

Filter articles

Showing 41 to 50 of 3113 results

Gilead accused of illegally paying to delay HIV drug competition

US22-09-2020Muireann Bolger

Biopharmaceutical company Gilead is being sued for allegedly scheming to prevent a generic rival from releasing a competing version of its HIV drug Truvada, according to a class action lawsuit filed by investors in the drug manufacturer.

Boehringer Ingelheim loses parasite control patent appeal

Australia21-09-2020Sarah Morgan

The Federal Court of Australia has rejected Boehringer Ingelheim’s animal health unit's attempt to stop the registration of a patent owned by Intervet International on various grounds.

LSPN Connect: Challenges in the US patent landscape

US21-09-2020Muireann Bolger

Innovations in life sciences have dramatically advanced the quality of US healthcare, while diagnostic tests and drug therapies that once seemed beyond our grasp have now become standard.

Biogen loses another battle over MS drug patent

US21-09-2020Muireann Bolger

In a blow for biotechnology company, Biogen, a US federal judge has ruled that its lone surviving patent on multiple-sclerosis drug Tecfidera should remain invalid because the matter had already been resolved by another court.

EPO revokes Copaxone patent, clears path for Mylan

EU17-09-2020Sarah Morgan

The European Patent Office has invalidated and revoked a patent related to Teva’s multiple sclerosis drug Copaxone, in a win for Mylan.

Merck & Co to buy $1bn stake in Seattle Genetics

US16-09-2020Sarah Morgan

Merck & Co is set to make a $1 billion investment in biotech company Seattle Genetics, as the companies collaborate to develop and sell Seattle Genetics’ cancer therapy, ladiratuzumab vedotin.

Orexo sues Sun Pharma over opioid dependence generic

Sweden, US16-09-2020Sarah Morgan

Swedish pharmaceutical company Orexo has taken India-based Sun Pharmaceutical to court in the US, over its plans to launch a generic version of Orexo’s opioid dependence treatment.

Judge gives initial approval to Actavis $20m antitrust deal

US15-09-2020Sarah Morgan

A Massachusetts judge has provided her preliminary approval to a $19.9 million settlement in a class action antitrust suit brought against pharmaceutical company Actavis. 

Broad and ERS Genomics both claim victory in latest CRISPR ruling

US14-09-2020Sarah Morgan

The Broad Institute and ERS Genomics, a company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, have both claimed victory in the latest round of the CRISPR inventorship battle.

Gilead to buy Immunomedics for $21bn

US14-09-2020Sarah Morgan

Gilead Sciences is set to acquire biopharmaceutical company Immunomedics in a $21 billion deal, further strengthening its oncology expertise.

Showing 41 to 50 of 3113 results

LSIPR